Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 152

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Evaluation of the Efficacy and Safety of Once-a-Day Dosing of Tadalafil 5mg and 10mg in the Treatment of Erectile Dysfunction: Results of a Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial

Porst, Hartmut, Giuliano, François, Glina, Sidney, Ralph, David, Casabé, Adolfo R., Elion-Mboussa, Albert, Shen, Wei, Whitaker, J. Steve·2006·European Urology

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.eururo.2006.02.052

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 more claim about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Research works printed but not linked: 22

  1. Padma-Nathan, 2001, On-demand IC351 (Cialis(trademark)) enhances erectile function in patients with erectile dysfunction, Int J Impot Res, 13, 2, 10.1038/sj.ijir.3900631 · DOI
  2. Porst, 2001, a new highly selective PDE5 inhibitor, improves erectile function irrespective of the baseline severity and aetiology of ED or age of patient, Eur Urol, 39, 17
  3. Hanson-Divers, 1998, Health outcomes variables important to patients in the treatment of erectile dysfunction, J Urol, 159, 1541, 10.1097/00005392-199805000-00037 · DOI
  4. Carson, 2004, The efficacy and safety of tadalafil: an update, BJU Int, 93, 1276, 10.1111/j.1464-410X.2004.04819.x · DOI
  5. Young, 2005, Tadalafil improved erectile function at twenty-four and thirty-six hours after dosing in men with erectile dysfunction: US trial, J Androl, 26, 310, 10.2164/jandrol.04126 · DOI
  6. McMahon, 2005, Comparison of efficacy, safety, and tolerability of on-demand tadalafil and daily dosed tadalafil for the treatment of erectile dysfunction, J Sex Med, 2, 415, 10.1111/j.1743-6109.2005.20360.x · DOI · Paper page
  7. Mirone, 2005, An evaluation of an alternative dosing regimen with tadalafil, 3 times/week, for men with erectile dysfunction: SURE study in 14 European countries, Eur Urol, 47, 846, 10.1016/j.eururo.2005.02.019 · DOI
  8. Debusk, 2000, Management of sexual dysfunction in patients with cardiovascular disease: Recommendations of the Princeton consensus panel, Am J Cardiol, 86, 175, 10.1016/S0002-9149(00)00896-1 · DOI · Paper page
  9. Dunnett, 1955, A multiple comparison procedure for comparing several treatments with a control, J Amer Statist Assoc, 50, 1096, 10.1080/01621459.1955.10501294 · DOI
  10. McMahon, 2004, Efficacy and safety daily tadalafil in men with erectile dysfunction previously unresponsive to on-demand tadalafil, J Sex Med, 1, 292, 10.1111/j.1743-6109.04042.x · DOI · Paper page
  11. Montorsi, 2004, Tadalafil in the treatment of erectile dysfunction following bilateral nerve sparing radical retropubic prostatectomy: A randomized, double-blind, placebo controlled trial, J Urol, 172, 1036, 10.1097/01.ju.0000136448.71773.2b · DOI · Paper page
  12. Brock, 2002, Efficacy and safety of tadalafil for the treatment of erectile dysfunction: Results of integrated analyses, J Urol, 168, 1332, 10.1016/S0022-5347(05)64442-4 · DOI · Paper page
  13. Saenz de Tejada, 2002, Effects of tadalafil on erectile dysfunction in men with diabetes, Diabetes Care, 25, 2159, 10.2337/diacare.25.12.2159 · DOI · Paper page
  14. Skoumal, 2004, Efficacy and treatment satisfaction with on-demand tadalafil (Cialis) in men with erectile dysfunction, Eur Urol, 46, 362, 10.1016/j.eururo.2004.04.026 · DOI
  15. Montorsi, 2004, Long-term safety and tolerability of tadalafil in the treatment of erectile dysfunction, Eur Urol, 45, 339, 10.1016/j.eururo.2003.11.010 · DOI
  16. Jackson, 2004, Update on clinical trials of tadalafil demonstrates no increased risk of cardiovascular adverse events, J Sex Med, 1, 161, 10.1111/j.1743-6109.2004.04024.x · DOI
  17. Chockalingam, 2005, Efficacy and optimal dose of sildenafil in primary pulmonary hypertension, Int J Cardiol, 99, 91, 10.1016/j.ijcard.2003.12.023 · DOI
  18. Kukreja, 2004, Cardioprotection with phosphodiesterase-5 inhibition - A novel preconditioning strategy, J Mol Cell Cardiol, 36, 165, 10.1016/j.yjmcc.2003.11.001 · DOI
  19. Behr-Roussel, 2005, Chronic sildenafil improves erectile function and endothelium-dependent cavernosal relaxations in rats: Lack of tachyphylaxis, Eur Urol, 47, 87, 10.1016/j.eururo.2004.09.005 · DOI
  20. Caretta, 2005, Resumption of spontaneous erections in selected patients affected by erectile dysfunction and various degrees of carotid wall alteration: Role of tadalafil, Eur Urol, 48, 326, 10.1016/j.eururo.2005.01.013 · DOI
  21. Desouza, 2002, Acute and prolonged effects of sildenafil on brachial artery flow-mediated dilatation in type 2 diabetes, Diabetes Care, 25, 1336, 10.2337/diacare.25.8.1336 · DOI
  22. Rosano, 2005, Chronic treatment with tadalafil improves endothelial function in men with increased cardiovascular risk, Eur Urol, 47, 214, 10.1016/j.eururo.2004.10.002 · DOI · Paper page

Cited by

See all 152

Metadata

Authors
Porst, H., Giuliano, F., Glina, S., Ralph, D., Casabé, A. R., Elion-Mboussa, A., Shen, W., & Whitaker, J. S.
Venue
European Urology
Publisher
Elsevier BV
Published
2006-08
Volume
50
Issue
2
Pages
351-359
ISSN
0302-2838
Cited by
152
References
5
Language
en
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Evaluation of the Efficacy and Safety of Once-a-Day Dosing of Tadalafil 5mg and 10mg in the Treatment of Erectile Dysfunction: Results of a Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial. https://app.cochat.ai/papers/10.1016/j.eururo.2006.02.052
The paper
Porst, H., Giuliano, F., Glina, S., Ralph, D., Casabé, A. R., Elion-Mboussa, A., Shen, W., & Whitaker, J. S. (2006). Evaluation of the Efficacy and Safety of Once-a-Day Dosing of Tadalafil 5mg and 10mg in the Treatment of Erectile Dysfunction: Results of a Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial. European Urology. https://doi.org/10.1016/j.eururo.2006.02.052

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.